Summary by Moomoo AI
FOXO Technologies Inc. reported financial results for the quarter ended March 31, 2024, with total revenue at $7, a decrease from $13 in the same period the previous year. The company experienced a net loss of $1,504, an improvement from a net loss of $7,639 in the prior year's quarter. The reduced net loss was primarily due to a decrease in operating expenses, which fell from $7,405 to $1,186, driven by lower research and development costs, management contingent share plan expenses, and selling, general and administrative expenses. Non-operating expenses increased slightly due to higher interest expenses. The company also recognized a deemed dividend of $656 related to the extension of certain warrants. FOXO Technologies continues to focus on commercializing epigenetic biomarker technology and has paused sales of...Show More
